Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Neoplasms 15 Breast Neoplasms 13 Stomach Neoplasms 12 Prostatic Neoplasms 12 Colorectal Neoplasms 11 Pancreatic Neoplasms 9 Lung Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Carcinoma, Hepatocellular 7 Endometrial Neoplasms 5 Colonic Neoplasms 4 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Polycystic Ovary Syndrome 3 Ovarian Neoplasms 3 Head and Neck Neoplasms 3 Gastrointestinal Stromal Tumors 3 Gastrointestinal Neoplasms 3 Esophageal Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Skin Neoplasms 2 Salivary Gland Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Peritoneal Neoplasms 2 Papillomavirus Infections 2 Obesity 2 Multiple Myeloma 2

Interventions

Surveys and Questionnaires 4 trastuzumab deruxtecan 1 apixaban 1 X-Rays 1 Surgical Procedures, Operative 1 Rivaroxaban 1 Quality of Life 1 Psychiatric Rehabilitation 1 Patient Reported Outcome Measures 1 Observation 1 Molecular Diagnostic Techniques 1 Magnetic Resonance Spectroscopy 1 Immunotherapy 1 Hysterectomy 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Heparin, Low-Molecular-Weight 1 Hematologic Tests 1 Drug Therapy 1 Chemoradiotherapy 1 CA-125 Antigen 1 Buthionine Sulfoximine 1 Brachytherapy 1 Biological Therapy 1 Anticoagulants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Vaginal Neoplasms × Observation × Clear all

NCT06514235 2025-08-19

EMBRAVE

Erasmus Medical Center

Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡